SPARX3: Study In Parkinson Disease of Exercise Phase 3 Clinical Trial
HUM00180641
We are seeking volunteers to participate in a clinical research trial to learn more about the effects of aerobic exercise on people with Parkinson’s disease.
Who can participate?
- Diagnosed with Parkinson’s disease within the last 3 years
- Age 40-80 years
- Not yet taking medication for your PD symptoms / No use of PD medication within past 60 days
- You do not plan to start medication for PD within the next 6 months
- Are willing to take part in a regular treadmill exercise program 4 times per week for 18 months and participate in study visits periodically for 24 months
- Generally healthy, without any uncontrolled or unstable cardiovascular, metabolic, or renal disease
- Does not have any disorders that interfere with their ability to perform endurance exercises
- Less than 120 minutes per week of moderate intensity endurance exercise in the last 6 months
- Not allergic to iodinated products or hypersensitive to DaTscan™ SPECT
- Not currently pregnant or plan to become pregnant or plan to become pregnant in next 12 months
- Are not already participating in a structured exercise program
- Able to travel to the University of Michigan periodically for study related visits
You will undergo/receive:
- Medical history and health examination
- Physical and cognitive assessments
- Questionnaires
- Blood draws
- Exercise tests
- DaTscan brain imaging
- Up to $300 upon completion of the study
STUDY DETAILS:
Preliminary Screenings – Before participating in the study, you will undergo screenings at the University of Michigan School of Kinesiology, Domino Farms and/or the University Hospital. The first screening visit will include a blood draw, questionnaires, a physical and neurological exam, a cognitive assessment, and detailed medical history survey. If you pass the first screening, you will have a DaTscan (brain imaging).
If you are deemed eligible based on the results of the preliminary screenings, you will be enrolled into our study.
The study consists of three (3) distinct phases: Baseline Testing, 18-Month Exercise Intervention, and Post Testing.
- Baseline Visit: We want to determine your abilities prior to beginning study intervention. This visit will include another blood draw, questionnaires, a cognitive assessment, and exercise testing.
- 18-Month Study Period: You will be randomly assigned to one of two exercise groups: moderate (60-65% HRmax) or high (80-85% HRmax) intensity. You will be performing aerobic treadmill exercise 4 times per week for 18 months. Heart rate will be monitored during these exercise sessions. You will begin exercising at our facility under the supervision of an exercise trainer. Once the exercise trainer determines you can perform the exercise safely and correctly on your own, you may complete your exercise sessions at home or another exercise facility of your choice. You will meet with the research team twice per month. You will also be asked to return every 3 months to re-evaluate several measures we collect throughout your study participation.
- Post Testing: Your final study visit will take place around the 24-month time point. This visit will include an assessment of your current status and progression of your Parkinson’s disease, questionnaires, and a blood draw.
If interested, please contact Kendell Lewis at (734) 647-2706; [email protected].